{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "MKTX",
  "name": "MarketAxess Holdings, Inc.",
  "url": "https://orbyd.app/dossiers/MKTX/",
  "json_url": "https://orbyd.app/dossiers/MKTX.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a5",
    "n": 5
  },
  "current_thesis": "ICE's $167.00 all-cash agreement signed 2026-07-30 converted MKTX into a spread instrument: the 2026-08-07 close of $162.53 leaves $4.47 gross against an H1 2027 guided close. The operating narrative is fully priced and the issuer has suspended guidance, earnings calls and volume releases — HSR clearance is the only live variable.",
  "invalidation_trigger": "A daily close below $155 (gap to the $167.00 cash price widens to $12.00 — completion odds repricing, not just a longer clock), or an HSR second request disclosed before the preliminary merger proxy is filed.",
  "catalyst_date": "2026-08-19",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "m-and-a-special-situations",
    "semi-foundry-equipment"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Deal-pending disclosure regime since 2026-07-30: 2026 guidance withdrawn, earnings calls suspended, monthly volume releases discontinued until close or termination.",
    "Merger agreement permits regular quarterly dividends in the ordinary course; $0.78 declared, record 2026-08-19, payable 2026-09-02.",
    "Termination fees: $148.8M payable by MarketAxess (superior proposal / recommendation change); $327.4M payable by ICE if antitrust prevents closing.",
    "Outside date 2027-07-29, extendable by up to two automatic six-month periods where only antitrust and certain governmental approvals remain outstanding.",
    "Consideration is a fixed $167.00 cash per share — no exchange ratio, no collar, and no disclosed financing condition."
  ],
  "body_markdown": "## Current Thesis\nOn 2026-07-30 Intercontinental Exchange agreed to acquire MarketAxess for $167.00 per share in cash — roughly $6.0B equity value, ~$5.7B enterprise value, a 33% premium to the 2026-07-29 close — with closing guided to H1 2027. The equity re-rated the same session and now trades as a deal instrument: the 2026-08-07 close of $162.53 sits $4.47 under terms, a gross gap of 2.8%. What is on offer is the probability-weighted difference between HSR clearance and a break. The operating business has been removed from the equation: the company withdrew 2026 guidance, cancelled its scheduled 2026-08-07 earnings call and suspended monthly volume releases on the day of announcement.\n\n## Bull Case\n- Definitive agreement, unanimously approved by both boards, all cash at a fixed $167.00 with no exchange ratio and no collar; ICE has said it will fund with new debt — bonds, term loans and commercial paper (joint release, 2026-07-30).\n- ICE agreed to a $327.4M parent termination fee payable if antitrust prevents closing, against a $148.8M company fee. The acquirer accepted regulatory downside at roughly 2.2x the target-side fee (MKTX Form 8-K, 2026-07-30).\n- Vote mechanics are light: adoption requires a majority of outstanding shares. The price is 33% above the 2026-07-29 close and above two July sell-side marks — Morgan Stanley Equal-Weight PT $129 (2026-07-10) and Piper Sandler Neutral PT $128 (2026-07-15).\n- The agreement permits regular quarterly dividends in the ordinary course. A $0.78 dividend is declared, record 2026-08-19, payable 2026-09-02, which accrues to holders through the pendency period.\n- The business is not decaying into the deal: Q2 2026 revenue $218.4M, net income $68.3M, diluted EPS $1.93, 41.1% operating margin, portfolio trading ADV a record $2.0B (+33% YoY) and block trading ADV $5.9B (+11% YoY).\n\n## Bear Case\n- The payoff is lopsided. $4.47 of gross upside sits against a downside the market itself marked in July: standalone targets of $128–129 dated 2026-07-10 and 2026-07-15. A termination re-prices the equity roughly 20%+ lower versus 2.8% of remaining spread.\n- The parties wrote for a long review. Outside date 2027-07-29, with up to two automatic six-month extensions where only antitrust and certain governmental approvals remain outstanding — an envelope reaching mid-2028.\n- ICE already operates fixed income venues and bond pricing data; MarketAxess is the dominant electronic venue in US credit. Overlap analysis at HSR is the single live variable and is opaque until the merger proxy discloses the filing date and whether a second request landed.\n- The $167.00 cash price is below the $192.55 52-week high, which gives an unhappy long-term holder a reference point for calling the price inadequate ahead of the vote.\n- Under the suspended-disclosure regime, a loss of US credit share or an ADV downturn would not surface publicly before the deal closes or breaks.\n\n## Setup & Price Structure\n- 2026-08-07 close $162.53; 52-week high $192.55 (-15.6%); three-month return +10.8%, essentially all of it the 2026-07-30 gap.\n- RSI(14) at 94.0 is the arithmetic residue of a one-day repricing to terms. Momentum and breadth readings carry no information on a signed cash deal; the price is pinned by arbitrage to $167.00 less time value less break probability.\n- $167.00 is the effective ceiling absent a competing bid, and the no-shop restricts solicitation (fiduciary out preserved, $148.8M fee). The floor is undefined and would be set in the pre-deal standalone zone the $128–129 targets described.\n- Spread arithmetic: at $162.53 the gap to terms is $4.47. A tape at $155 is a gap of $12.00 — the market assigning materially higher break odds than routine timing friction.\n- Narrative life-cycle: **SATURATED**. Mainstream coverage arrived and was exhausted inside 24 hours (Business Wire, CNBC, Bond Buyer, 2026-07-30); sell-side marked straight to terms the next morning (UBS downgrade to Neutral, PT $167, 2026-07-31); and the issuer switched off its own news flow the same week. Positioning evidence is what a post-announcement deal book looks like — event-driven ownership replacing fundamental ownership, no earnings date to trade, no monthly volume prints to react to, and a price pinned within 2.8% of a fixed number.\n\n## Catalyst Calendar (next 30 days)\n\n- **2026-08-19** — Record date for the declared $0.78 quarterly dividend. Confirms the ordinary-course dividend carve-out is being exercised during the pendency period.\n- **2026-09-02** — Dividend payment date for the same $0.78.\n- **~2026-09 (est.)** — Preliminary merger proxy on Schedule 14A expected. First document to disclose the HSR filing date, background of the merger, management projections and the special-meeting timetable.\n\n## Elapsed catalysts\n\n- **No earnings event in the window.** The 2026-08-07 call was cancelled and monthly volume releases were suspended on 2026-07-30, so the next scheduled company disclosure is the proxy. *(passed 2d ago)*\n\n## What Would Change Our Mind\nThe thing that breaks first is the spread, and the level at which it stops reading as ordinary timing friction. A daily close below $155 puts the gap to the $167.00 cash price at $12.00 and would say the market has repriced completion odds rather than merely discounted a longer clock. Secondary conditions that would carry the same message without a price move: a second request under HSR disclosed in a filing or in ICE's next quarterly commentary; a preliminary proxy that fails to appear through Q3 2026; or ICE softening the H1 2027 close language at its own Q3 print. The reverse also resolves cleanly — expiry of the HSR waiting period without a second request, a proxy setting a shareholder vote inside 2026, and ISS/Glass Lewis support would compress the spread toward a rate-of-return floor and remove most of what is currently being debated.\n\n## Correlation Notes\n- Since 2026-07-30 MKTX has decoupled from the trading-venue complex it used to move with (Tradeweb, CME, Cboe) and from credit-spread and bond-volume beta. Residual drivers are US antitrust news flow, the discount rate applied to a fixed $167.00 payable in H1 2027, and ICE's funding capacity.\n- The financing leg sits with ICE, raising new debt into a 30-year Treasury yield at a 19-year high per market coverage dated 2026-07-30. Higher funding cost pressures ICE's accretion math; it does not move the fixed cash consideration.\n- Broad-index drawdowns transmit to announced-deal spreads through arbitrage-book deleveraging, which is now the main channel by which general equity risk reaches this quote at all.",
  "first_seen": "2026-08-04",
  "last_analyzed": "2026-08-08T09:35:31+00:00",
  "last_synthesized": "2026-08-08",
  "last_update_source": "watchlist_research",
  "license": "Content © orbyd. Cite the canonical URL."
}